LATAM Airlines Group S.A. (LTM)

LATAM Airlines Group S.A. has decided not to restart Aventus for any part of its fleet and will not restart ClearPath for its short-haul fleet, causing AVTECH's annual recurring revenue to decrease by approximately SEK 8.5 million. However, LATAM will continue to use ClearPath for its long-haul operations due to demonstrated cost savings. AVTECH expresses disappointment but remains committed to supporting ClearPath for LATAM's long-haul fleet.

LATAM Airlines Group SA (LTM) shares have recently fallen by 3.4% to $50.54, making the stock 21.6% overvalued according to GuruFocus's GF Value™ estimate of $41.56. Despite this overvaluation, the stock holds an above-average GF Score™ of 72/100, with strong valuation and momentum but average financial strength and profitability. The absence of insider transactions and mixed guru activity suggest caution for potential investors.

This article provides a detailed financial overview and analysis of LATAM Airlines Group SA (LTM). It includes current stock price, key financial figures, technical analysis, analyst ratings (predominantly Buy with a target price of $73.50), upcoming earnings forecast, company profile, and ownership details. The company operates in passenger and cargo air transportation across the Americas, Europe, and Oceania.

LATAM Airlines Group S.A. (NYSE:LTM) has received a consensus "Buy" rating from eight brokerages, with an average 12-month price target of $66.27, significantly above its recent trading price of $52.35. The airline recently surpassed quarterly earnings expectations, reporting $0.44 EPS against an estimated $0.41, and revenue of $4.12 billion compared to the $4.06 billion consensus. Several institutional investors have increased their stakes in LTM, while the stock trades below its 52-week high, indicating potential for growth.

LATAM Airlines Group (SNSE:LTM) reported strong earnings, and while the stock price didn't react significantly, underlying factors suggest a positive future for the company. The company's accrual ratio of -0.20 indicates that its free cash flow significantly exceeded its statutory profit, with US$2.1 billion in free cash flow against US$1.56 billion in statutory profit. This strong conversion of profit to free cash flow, coupled with a 40% increase in EPS over the last twelve months, suggests that the company's underlying earnings potential is better than its statutory profit might imply.